KEGG   PATHWAY: xtr04370
Entry
xtr04370                    Pathway                                
Name
VEGF signaling pathway - Xenopus tropicalis (tropical clawed frog)
Description
There is now much evidence that VEGFR-2 is the major mediator of VEGF-driven responses in endothelial cells and it is considered to be a crucial signal transducer in both physiologic and pathologic angiogenesis. The binding of VEGF to VEGFR-2 leads to a cascade of different signaling pathways, resulting in the up-regulation of genes involved in mediating the proliferation and migration of endothelial cells and promoting their survival and vascular permeability. For example, the binding of VEGF to VEGFR-2 leads to dimerization of the receptor, followed by intracellular activation of the PLCgamma;PKC-Raf kinase-MEK-mitogen-activated protein kinase (MAPK) pathway and subsequent initiation of DNA synthesis and cell growth, whereas activation of the phosphatidylinositol 3' -kinase (PI3K)-Akt pathway leads to increased endothelial-cell survival. Activation of PI3K, FAK, and p38 MAPK is implicated in cell migration signaling.
Class
Environmental Information Processing; Signal transduction
Pathway map
xtr04370  VEGF signaling pathway
xtr04370

Other DBs
GO: 0048010
Organism
Xenopus tropicalis (tropical clawed frog) [GN:xtr]
Gene
100038089  vegfa; vascular endothelial growth factor A precursor [KO:K05448]
100487501  kdr; vascular endothelial growth factor receptor 2 [KO:K05098] [EC:2.7.10.1]
101731988  sh2d2a; SH2 domain-containing protein 2A [KO:K08273]
100496658  1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116] [EC:3.1.4.11]
100496674  plcg1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 [KO:K01116] [EC:3.1.4.11]
100496686  plcg2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X2 [KO:K05859] [EC:3.1.4.11]
780209  prkca; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
100038043  prkcb; protein kinase C beta type [KO:K19662] [EC:2.7.11.13]
100496779  prkcg; protein kinase C gamma type isoform X2 [KO:K19663] [EC:2.7.11.13]
549672  sphk1; sphingosine kinase 1 [KO:K04718] [EC:2.7.1.91]
100494664  sphk2; sphingosine kinase 2 [KO:K04718] [EC:2.7.1.91]
549757  hras; GTPase HRas [KO:K02833]
493396  kras; Kirsten rat sarcoma viral oncogene homolog [KO:K07827]
100485959  krasl; GTPase KRas isoform X2 [KO:K07827]
549517  nras; GTPase NRas [KO:K07828]
549871  raf1; RAF proto-oncogene serine/threonine-protein kinase [KO:K04366] [EC:2.7.11.1]
493420  map2k1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
549881  mapk1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
100145731  pla2g4a; cytosolic phospholipase A2 [KO:K16342] [EC:3.1.1.4]
100485430  jmjd7-pla2g4b; cytosolic phospholipase A2 delta [KO:K16342] [EC:3.1.1.4]
100497525  pla2g4f; cytosolic phospholipase A2 zeta [KO:K16342] [EC:3.1.1.4]
105948093  pla2g4d; cytosolic phospholipase A2 delta isoform X1 [KO:K16342] [EC:3.1.1.4]
100144934  ppp3ca; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform [KO:K04348] [EC:3.1.3.16]
100037857  ppp3cc; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform [KO:K04348] [EC:3.1.3.16]
100037840  ppp3cb; serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform [KO:K04348] [EC:3.1.3.16]
395037  ppp3r1; calcineurin subunit B type 1 [KO:K06268]
100490186  nfatc2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X1 [KO:K17332]
595089  ptgs2; prostaglandin G/H synthase 2 precursor [KO:K11987] [EC:1.14.99.1]
733890  ptk2; focal adhesion kinase 1 isoform X4 [KO:K05725] [EC:2.7.10.2]
100487416  shc2; SHC-transforming protein 2 [KO:K17447]
100216044  pxn; paxillin [KO:K05760]
493389  cdc42; cell division control protein 42 homolog isoform 1 [KO:K04393]
448296  mapk14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]
549834  mapk12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]
100101766  mapk11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
100144715  mapk13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
100145045  mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]
550101  mapkapk2; MAP kinase-activated protein kinase 2 [KO:K04443] [EC:2.7.11.1]
780323  mapkapk3; MAP kinase-activated protein kinase 3 [KO:K04444] [EC:2.7.11.1]
780278  hspb1; heat shock protein beta-1 [KO:K04455]
496893  src; proto-oncogene tyrosine-protein kinase Src [KO:K05704] [EC:2.7.10.2]
780390  pik3cb; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
100144924  pik3ca; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
549983  pik3r3; phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649]
100486835  pik3r1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
100497001  pik3r2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
448118  rac1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
496738  rac2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
100101726  rac3; ras-related C3 botulinum toxin substrate 3 [KO:K07861]
100144709  akt2; RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
100490038  akt1; RAC-alpha serine/threonine-protein kinase isoform X2 [KO:K04456] [EC:2.7.11.1]
100486016  nos3; nitric oxide synthase, endothelial [KO:K13242] [EC:1.14.13.39]
100144708  casp9; caspase-9 [KO:K04399] [EC:3.4.22.62]
100487418  bad; bcl2-associated agonist of cell death [KO:K02158]
Compound
C00076  Calcium cation
C00165  Diacylglycerol
C00533  Nitric oxide
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01312  Prostaglandin I2
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Cross MJ, Dixelius J, Matsumoto T, Claesson-Welsh L.
  Title
VEGF-receptor signal transduction.
  Journal
Trends Biochem Sci 28:488-94 (2003)
DOI:10.1016/S0968-0004(03)00193-2
Reference
  Authors
Matsumoto T, Claesson-Welsh L.
  Title
VEGF receptor signal transduction.
  Journal
Sci STKE 2001:RE21 (2001)
DOI:10.1126/stke.2001.112.re21
Reference
  Authors
Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA.
  Title
Vascular endothelial growth factor and angiogenesis.
  Journal
Pharmacol Rev 56:549-80 (2004)
DOI:10.1124/pr.56.4.3
Reference
  Authors
Takahashi H, Shibuya M.
  Title
The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.
  Journal
Clin Sci (Lond) 109:227-41 (2005)
DOI:10.1042/CS20040370
Reference
  Authors
Zachary I.
  Title
VEGF signalling: integration and multi-tasking in endothelial cell biology.
  Journal
Biochem Soc Trans 31:1171-7 (2003)
DOI:10.1042/bst0311171
Reference
  Authors
Munoz-Chapuli R, Quesada AR, Angel Medina M.
  Title
Angiogenesis and signal transduction in endothelial cells.
  Journal
Cell Mol Life Sci 61:2224-43 (2004)
DOI:10.1007/s00018-004-4070-7
Reference
  Authors
Lamalice L, Houle F, Jourdan G, Huot J.
  Title
Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38.
  Journal
Oncogene 23:434-45 (2004)
DOI:10.1038/sj.onc.1207034
Reference
  Authors
Shu X, Wu W, Mosteller RD, Broek D.
  Title
Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases.
  Journal
Mol Cell Biol 22:7758-68 (2002)
DOI:10.1128/MCB.22.22.7758-7768.2002
Related
pathway
xtr00590  Arachidonic acid metabolism
xtr04010  MAPK signaling pathway
xtr04020  Calcium signaling pathway
xtr04510  Focal adhesion
KO pathway
ko04370   
LinkDB

DBGET integrated database retrieval system